ANAPTYSBIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$48.28
-0.74%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-0.7%
3 months
-10.0%
6 months
-27.7%
1 year
+90.9%
Year to date
+43.6%
52-week range
$22.95 – $69.81
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.44B
P/E
7.4
P/B
136.4
P/S
6.1
Revenue
$237.61M
Net income
$195.72M
Diluted EPS
5.74
Gross margin
100.00%
Net margin
82.40%
Return on equity
2515.20%
Total debt
$269.59M
Cash
$133.83M
Free cash flow
$18.16M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $27.49M | $183.88M | 100.00% | 668.90% | -$26.62M |
| Mar 31, 2026 | $25.56M | -$52.88M | 100.00% | -206.90% | -$25.94M |
| Dec 31, 2025 | $108.25M | $49.61M | 100.00% | 45.80% | $98M |
| Sep 30, 2025 | $76.32M | $15.11M | 100.00% | 19.80% | -$27.37M |
| Jun 30, 2025 | $22.26M | -$38.63M | 100.00% | -173.50% | -$40.28M |
| Mar 31, 2025 | $27.77M | -$39.33M | 100.00% | -141.60% | -$10.74M |
| Dec 31, 2024 | $43.11M | -$21.78M | 100.00% | -50.50% | -$66.94M |
| Sep 30, 2024 | $30.02M | -$32.85M | 100.00% | -109.40% | -$10.13M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ANAB news
All market newsNo ticker-linked stories are in the current archive.